Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 304.60
-8.00 (-2.56%)
May 19, 2026, 12:35 PM CET
Zealand Pharma Cash Flow Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 6,396 | 6,455 | -1,079 | -703.74 | -1,202 | -1,018 |
Depreciation & Amortization | 29.01 | 24.01 | 23.12 | 20.12 | 101.57 | 27.82 |
Other Amortization | 20.38 | 20.38 | 16.49 | 1.2 | 1.34 | - |
Asset Writedown & Restructuring Costs | - | - | - | 4.71 | -0.7 | 6.52 |
Stock-Based Compensation | 124.89 | 115.89 | 87.03 | 61.43 | 52.29 | 53.5 |
Other Operating Activities | -198.08 | -171.08 | -96.39 | 138.51 | 81.67 | -130.47 |
Change in Accounts Receivable | -11.26 | -88.26 | -48.96 | -6.76 | 26.64 | -64.49 |
Change in Inventory | 10.7 | 10.7 | -2.76 | 9.34 | 18.22 | -52.77 |
Change in Accounts Payable | -254.34 | -178.34 | 89.92 | 39.84 | 21.55 | -49.06 |
Change in Income Taxes | 547.06 | 546.06 | -4.62 | - | - | - |
Change in Other Net Operating Assets | -303.43 | -202.43 | 84.19 | 9.68 | -56.25 | - |
Operating Cash Flow | 6,361 | 6,532 | -930.82 | -425.67 | -942.31 | -1,212 |
Capital Expenditures | -37.37 | -33.37 | -10.05 | -11.24 | -11.71 | -22.13 |
Sale (Purchase) of Intangibles | -34.71 | -35.71 | -3.1 | -12.51 | - | - |
Investment in Securities | -2,847 | -2,179 | -7,293 | -1,070 | 186.58 | - |
Other Investing Activities | - | - | - | - | 106.39 | 4.01 |
Investing Cash Flow | -2,920 | -2,249 | -7,307 | -1,094 | 281.26 | -18.12 |
Long-Term Debt Issued | - | - | 369.87 | - | - | 647.91 |
Long-Term Debt Repaid | - | -20.16 | -16.44 | -543.43 | -449.81 | -14.72 |
Net Debt Issued (Repaid) | -25.16 | -20.16 | 353.43 | -543.43 | -449.81 | 633.19 |
Issuance of Common Stock | 47.15 | 49.15 | 8,523 | 1,564 | 1,085 | 775.05 |
Repurchase of Common Stock | -407.17 | -407.17 | -351.83 | -41.6 | - | -28.59 |
Other Financing Activities | - | - | -236.58 | -71.91 | -47.35 | -46.9 |
Financing Cash Flow | -385.18 | -378.18 | 8,288 | 907.01 | 587.5 | 1,333 |
Foreign Exchange Rate Adjustments | 16.26 | -54.74 | 6.23 | -7.24 | 13.68 | 66.22 |
Net Cash Flow | 3,073 | 3,851 | 57.39 | -619.92 | -59.87 | 168.88 |
Free Cash Flow | 6,324 | 6,499 | -940.87 | -436.91 | -954.02 | -1,234 |
Free Cash Flow Margin | 68.43% | 70.52% | -1500.80% | -127.46% | -917.45% | -1136.94% |
Free Cash Flow Per Share | 88.40 | 90.83 | -14.16 | -7.72 | -20.65 | -28.79 |
Cash Interest Paid | 22.33 | 22.33 | 24.03 | 25.25 | 34.12 | 3.3 |
Cash Income Tax Paid | 567.37 | 567.37 | -11.16 | -11.3 | -9.28 | 41.63 |
Levered Free Cash Flow | 4,224 | 4,392 | -736.41 | -228.98 | -384.08 | -589.73 |
Unlevered Free Cash Flow | 4,223 | 4,393 | -728.89 | -213.78 | -349.29 | -587.18 |
Change in Working Capital | -11.27 | 87.73 | 117.76 | 52.1 | 10.16 | -166.33 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.